Back to search

Article

Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy response

2022-10-22

Abstract excerpt

1. Lung cancer is the leading cause of cancer death worldwide with 1.76 million people die as a result of the disease yearly. Analyzing high-throughput multiplexed images of tissues has recently emerged as a routine clinical procedure for early detection, clinical cancer diagnosis, treatment planning and prognosis for many cancer types including non-small cell lung cancer (NSCLC). Multiplexed images enable the pre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d1ddf89c-0700-563d-a721-b5d08dff3dcb
DOI
10.1101/2022.10.22.513219
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy responseDOI 10.1101/2022.10.22.513219
Select a neighboring publication to make it the new centre.